Gold prices slip after rallying on Powell rate cut talk
DELRAY BEACH, Fla. - PetMed Express, Inc. (NASDAQ:PETS), which operates under the PetMeds brand and owns PetCareRx, announced Tuesday it is postponing the release of its fourth quarter and fiscal year 2025 financial results. The company, currently trading at $4.19 and showing a strong 4.3% return over the past week, maintains a market capitalization of $86.5 million.
The company stated it needs additional time to complete its year-end audit process. The earnings release and conference call, originally scheduled for June 10, 2025, will now take place by June 16, 2025, according to the company’s statement.
PetMed Express, founded in 1996, operates as an online pet pharmacy through its PetMeds.com and PetCareRx.com websites, offering prescription and over-the-counter medications along with other pet products.
The company indicated in its press release statement that it plans to file its Annual Report on Form 10-K within the same timeframe as the rescheduled earnings announcement.
PetMed Express provides medications, food products, and supplies for dogs, cats, and horses through its digital platforms, according to the company.
In other recent news, PetMed Express announced a strategic partnership with Dutch, a virtual veterinary care provider. This collaboration aims to address the nationwide vet shortage by integrating Dutch’s telemedicine services with PetMed Express’s medication offerings, making pet healthcare more accessible. Additionally, Morgan Stanley has adjusted its outlook on PetMed Express, reducing the price target from $3.50 to $3.20 while maintaining an Underweight rating on the stock. The firm acknowledges the company’s strong market position but highlights challenges due to increasing competition.
PetMed Express has also made changes to its Board of Directors, appointing Peter Batushansky, a seasoned executive with extensive experience in retail and pet healthcare. This appointment follows the announcement of Dr. Gian Fulgoni’s upcoming retirement from the board. The company is undergoing a transformation with several leadership changes, including the appointment of Sandra Campos as CEO and President. These developments reflect PetMed Express’s commitment to expanding its online pet pharmacy business and enhancing its position in the pet wellness ecosystem.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.